These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 31887854)
1. Effects of the online computerized cognitive training program BEYNEX on the cognitive tests of individuals with subjective cognitive impairment and Alzheimer’s disease on rivastigmine therapy. Çinar N; Şahiner TAH Turk J Med Sci; 2020 Feb; 50(1):231-238. PubMed ID: 31887854 [TBL] [Abstract][Full Text] [Related]
2. Can a serious game-based cognitive training attenuate cognitive decline related to Alzheimer's disease? Protocol for a randomized controlled trial. Brill E; Krebs C; Falkner M; Peter J; Henke K; Züst M; Minkova L; Brem AK; Klöppel S BMC Psychiatry; 2022 Aug; 22(1):552. PubMed ID: 35962371 [TBL] [Abstract][Full Text] [Related]
3. The effects of an 8-week computerized cognitive training program in older adults: a study protocol for a randomized controlled trial. Ten Brinke LF; Best JR; Crockett RA; Liu-Ambrose T BMC Geriatr; 2018 Jan; 18(1):31. PubMed ID: 29378515 [TBL] [Abstract][Full Text] [Related]
4. Rivastigmine transdermal patch and capsule in Alzheimer's disease: influence of disease stage on response to therapy. Farlow MR; Grossberg GT; Meng X; Olin J; Somogyi M Int J Geriatr Psychiatry; 2011 Dec; 26(12):1236-43. PubMed ID: 22068922 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of rivastigmine transdermal therapy on low food intake in patients with Alzheimer's disease: The Attitude Towards Food Consumption in Alzheimer's Disease Patients Revive with Rivastigmine Effects study. Tsuno N; Mori T; Ishikawa I; Bando N; Park H; Matsumoto Y; Mori I; Tanaka M; Hirano T; Nakamura Y Geriatr Gerontol Int; 2019 Jul; 19(7):571-576. PubMed ID: 30864298 [TBL] [Abstract][Full Text] [Related]
6. A pilot randomized controlled trial evaluating an integrated treatment of rivastigmine transdermal patch and cognitive stimulation in patients with Alzheimer's disease. D'Onofrio G; Sancarlo D; Addante F; Ciccone F; Cascavilla L; Paris F; Elia AC; Nuzzaci C; Picoco M; Greco A; Panza F; Pilotto A Int J Geriatr Psychiatry; 2015 Sep; 30(9):965-75. PubMed ID: 25504466 [TBL] [Abstract][Full Text] [Related]
7. Effect of cholinergic treatment depends on cholinergic integrity in early Alzheimer's disease. Richter N; Beckers N; Onur OA; Dietlein M; Tittgemeyer M; Kracht L; Neumaier B; Fink GR; Kukolja J Brain; 2018 Mar; 141(3):903-915. PubMed ID: 29309600 [TBL] [Abstract][Full Text] [Related]
8. Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy. Wattmo C; Minthon L; Wallin ÅK Alzheimers Res Ther; 2016 Feb; 8():7. PubMed ID: 26883213 [TBL] [Abstract][Full Text] [Related]
9. Short-term computerized cognitive training does not improve cognition compared to an active control in non-demented adults aged 80 years and above. West RK; Rabin LA; Silverman JM; Moshier E; Sano M; Beeri MS Int Psychogeriatr; 2020 Jan; 32(1):65-73. PubMed ID: 30968798 [TBL] [Abstract][Full Text] [Related]
10. Selective Ability of Some CANTAB Battery Test Measures to Detect Cognitive Response to a Single Dose of Donepezil in Alzheimer Disease. Kuzmickienė J; Kaubrys G Med Sci Monit; 2015 Aug; 21():2572-82. PubMed ID: 26336931 [TBL] [Abstract][Full Text] [Related]
11. Improvement of spontaneous speech in early stage Alzheimer's with rivastigmine. Visch Brink EG; Van Rhee Temme W; Rietveld T; Krulder JW; Van Harskamp F; Van der Cammen TJ J Nutr Health Aging; 2009 Jan; 13(1):34-8. PubMed ID: 19151906 [TBL] [Abstract][Full Text] [Related]
12. Computerized Cognitive Training in Older Adults With Mild Cognitive Impairment or Dementia: A Systematic Review and Meta-Analysis. Hill NT; Mowszowski L; Naismith SL; Chadwick VL; Valenzuela M; Lampit A Am J Psychiatry; 2017 Apr; 174(4):329-340. PubMed ID: 27838936 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and Concurrent Validity of Computerized Brain Training Based on Everyday Living (BTEL) Based on Instrumental Activities of Living for Cognitively Healthy Old Individuals: A Preliminary Study. Asada T; Tanaka M; Araki W; Jon Lebowitz A; Kakuma T J Alzheimers Dis; 2024; 99(2):549-558. PubMed ID: 38701140 [TBL] [Abstract][Full Text] [Related]
14. Cerebral White Matter Changes on Therapeutic Response to Rivastigmine in Alzheimer's Disease. Ho BL; Kao YH; Chou MC; Yang YH J Alzheimers Dis; 2016 Aug; 54(1):351-7. PubMed ID: 27567838 [TBL] [Abstract][Full Text] [Related]
15. The Effects of Computerized Cognitive Training With and Without Physical Exercise on Cognitive Function in Older Adults: An 8-Week Randomized Controlled Trial. Ten Brinke LF; Best JR; Chan JLC; Ghag C; Erickson KI; Handy TC; Liu-Ambrose T J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):755-763. PubMed ID: 31054254 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of higher-dose 13.3 mg/24 h (15 cm2) rivastigmine patch on the Alzheimer's Disease Assessment Scale-cognitive subscale: domain and individual item analysis. Alva G; Isaacson R; Sadowsky C; Grossberg G; Meng X; Somogyi M Int J Geriatr Psychiatry; 2014 Sep; 29(9):920-7. PubMed ID: 24549933 [TBL] [Abstract][Full Text] [Related]
17. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease. Julayanont P; Brousseau M; Chertkow H; Phillips N; Nasreddine ZS J Am Geriatr Soc; 2014 Apr; 62(4):679-84. PubMed ID: 24635004 [TBL] [Abstract][Full Text] [Related]
18. The CITIRIVAD Study: CITIcoline plus RIVAstigmine in Elderly Patients Affected with Dementia Study. Castagna A; Cotroneo AM; Ruotolo G; Gareri P Clin Drug Investig; 2016 Dec; 36(12):1059-1065. PubMed ID: 27587069 [TBL] [Abstract][Full Text] [Related]